CLL-186 Interim Results From ASSURE: A Phase 3b Safety Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukemia by Opat, Stephen, Awan, Farrukh T., Fogliatto, Laura, Nikitin, Eugene, Czerwinski, Joanna, Santucci Alves da Silva, Rodrigo, Jujjavarapu, Srinivas, Samoilova, Olga, Dartigeas, Caroline, Tran, Hoa, de la Serna, Javier, Banerji, Versha, Magnano Mayer, Laura, Hart, Jason, von Tresckow, Julia, Poulsen, Christian B., Seong Eom, Ki, Merli, Michele, John, Ellie, Munley, Jiefen, Hakre, Shweta, Hermann, Richard, Niemann, Carsten U.

Get full text

Interim Results From ASSURE: A Phase 3b Safety Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukemia by Opat, Stephen, Awan, Farrukh T., Fogliatto, Laura, Nikitin, Eugene, Czerwinski, Joanna, Santucci Alves da Silva, Rodrigo, Jujjavarapu, Srinivas, Samoilova, Olga, Dartigeas, Caroline, Tran, Hoa, de la Serna, Javier, Banerji, Versha, Magnano Mayer, Laura, Hart, Jason, von Tresckow, Julia, Poulsen, Christian B., Seong Eom, Ki, Merli, Michele, John, Ellie, Munley, Jiefen, Hakre, Shweta, Hermann, Richard, Niemann, Carsten U.

Get full text

Treatment- Free Remission in Chronic Myeloid Leukemia -Experience of a Single Brazilian Private Institution Using Imatinib Copies by Centrone, Renato Torrescasana, Bellesso, Marcelo, Silva, Rodrigo Santucci, Dias, Daniela Ferreira, Bendit, Israel, Lima Alves, Jhony ARANHA, Bruniera, Felipe Ribeiro, Trunkel, Ariel Testasicca, da Silva, Adelson Alves

Get full text

Financial Impact of Imatinib Discontinuation in Brazil - a Real World Evidence Pharmacoeconomic Study in Chronic Myeloid Leukemia of a Private Institution by Centrone, Renato, Bellesso, Marcelo, Silva, Rodrigo Santucci, Ferreira, Joyce Barreto Marques da Rosa, Oliveira, Iohanã Gabriely Costa, Travassos, Luana Correa, Espadas, Caroline Jorge, Gomes, Tamyres Alves, Rodrigues, Mariana Nascimento Caiaffo, Silva, Adelson Alves

Get full text